SA
DMRA logo
Damora Therapeutics, Inc.(DMRA)
Closing price · checked 8:21 PM ETAbout this dataData status
$23.22▼-1.08 (-4.44%)
Extended:$23.22+0.00 (+0.00%)· 8:21 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Damora Therapeutics, Inc. (DMRA)

Operating Expenses

$304.02M

TTM · Period ending: · USD

DMRA logo

DMRA Operating Expenses

Latest reported$304.02M
DMRA Operating Expenses ($12.91M → $304.02M)
High-resolution chart · PNG

What is operating expenses?

Expenses from normal business operations (SG&A, R&D, etc.).

DMRA operating expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

Damora Therapeutics, Inc. Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)Change
210,872,000+1,161.50%
16,716,000−53.08%
35,627,000−41.32%
60,717,000+17.25%
51,786,000+54.82%
33,448,999−13.92%
38,860,000+201.08%
12,907,000—

Frequently asked questions: DMRA operating expenses

What is Damora Therapeutics, Inc. (DMRA)'s current operating expenses?

Damora Therapeutics, Inc. (DMRA)'s latest reported operating expenses (TTM) is $304.02M as of Sep 30, 2026. Expenses from normal business operations (SG&A, R&D, etc.).

How much historical operating expenses data is available for DMRA?

Stock Alarm Pro provides 8 dated annual fiscal periods observations for Damora Therapeutics, Inc. (DMRA)'s operating expenses, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare DMRA's operating expenses to peers or set an alert?

You can open DMRA's operating expenses in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on DMRA delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.